The MARIPOSA trials — implications for the treatment of EGFR-mutant NSCLC
Year: 2024
Type: other
Source: Nature Reviews Clinical Oncology
Institutions: Emory University, Winship Cancer Institute
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4401706027